Woodcliff Lake-based Par Pharmaceutical Companies Inc. announced Tuesday the appointment of Terrance J. Coughlin as its new chief operating officer.
According to the announcement, Coughlin will be responsible for the company’s global manufacturing activities, research and development efforts, and new product selection.
He most recently was president and CEO at Glenmark Generics Inc. USA/Glenmark Generics Limited, Par announced in a recent press release.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy